0001237899-19-000025.txt : 20191126 0001237899-19-000025.hdr.sgml : 20191126 20191126162950 ACCESSION NUMBER: 0001237899-19-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191125 FILED AS OF DATE: 20191126 DATE AS OF CHANGE: 20191126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 191251417 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-11-25 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research and Development Common Stock 2019-11-25 4 M 0 10000 52.03 A 32455 D Common Stock 2019-11-25 4 F 0 5994 362.75 D 26461 D Common Stock 2019-11-26 4 S 0 1422 363.58 D 25039 D Common Stock 2019-11-26 4 S 0 2284 364.2 D 22755 D Common Stock 2019-11-26 4 S 0 300 365.41 D 22455 D Common Stock 5736 I By 401(k) Plan Common Stock 7831 I by 2018 GRAT Non-Qualified Stock Option (right to buy) 52.03 2019-11-25 4 M 0 10000 0.0 D 2021-12-16 Common Stock 10000 88079 D Represents volume-weighted average price of sales of 1,422 shares of Company stock on November 26, 2019 at prices ranging from $363.07 to $363.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price. Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 26, 2019 at prices ranging from $364.00 to $364.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on November 26, 2019 at prices ranging from $365.26 to $365.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price. With respect to 75,000 underlying shares, the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 13,079 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. /s/**Neil Stahl 2019-11-26